Canlyniadau Chwilio - Terui, Yasuhito

Klebsiella pneumoniae primary liver abscess associated with ruxolitinib gan Kusano, Yoshiharu, Terui, Yasuhito, Ueda, Kyoko, Hatake, Kiyohiko

Cael y testun llawn Cael y testun llawn Cael y testun llawn

Epstein-Barr virus gastric ulcer associated with ruxolitinib gan Kusano, Yoshiharu, Terui, Yasuhito, Ueda, Kyoko, Hatake, Kiyohiko

Cael y testun llawn Cael y testun llawn Cael y testun llawn

Effective collaboration between hematologists and cardiologists facilitated successful control of reversible dasatinib-related pulmonary arterial hypertension and treatment-free re... gan Hua, Zhensheng, Oyakawa, Takuya, Ebihara, Aya, Terui, Yasuhito, Shiga, Taro

Cael y testun llawn Cael y testun llawn Cael y testun llawn

Preferential Production of Interleukin‐1β over Interleukin‐1 Receptor Antagonist Contributes to Proliferation and Suppression of Apoptosis in Leukemic Cells gan Furukawa, Yusuke, Kikuchi, Jiro, Terui, Yasuhito, Kitagawa, Seiichi, Ohta, Masatsugu, Miura, Yasusada, Saito, Masaki

Cael y testun llawn Cael y testun llawn Cael y testun llawn

Intravascular Large B-cell Lymphoma of the Bilateral Ovaries and Uterus in an Asymptomatic Patient with a t(11;22)(q23;q11) Constitutional Translocation gan Shigematsu, Yasuyuki, Matsuura, Motoki, Nishimura, Noriko, Tsuyama, Naoko, Takeuchi, Kengo, Terui, Yasuhito, Takeshima, Nobuhiro, Hatake, Kiyohiko

Cael y testun llawn Cael y testun llawn

Factors for the optimal selection of granulocyte colony-stimulating factor preparations and predictors for R-CHOP dose reductions/delays among patients with non-Hodgkin B-cell lymp... gan Yokoyama, Masahiro, Kusano, Yoshiharu, Inoue, Norihito, Nishimura, Noriko, Mishima, Yuko, Nukada, Tomoyuki, Hatake, Kiyohiko, Terui, Yasuhito

Cael y testun llawn Cael y testun llawn Cael y testun llawn

Radiation therapy for localized duodenal low-grade follicular lymphoma gan Harada, Arisa, Oguchi, Masahiko, Terui, Yasuhito, Takeuchi, Kengo, Igarashi, Masahiro, Kozuka, Takuyo, Harada, Ken, Uno, Takashi, Hatake, Kiyohiko

Cael y testun llawn Cael y testun llawn Cael y testun llawn

Clinical and prognostic significance of aberrant T-cell marker expression in 225 cases of de novo diffuse large B-cell lymphoma and 276 cases of other B-cell lymphomas gan Tsuyama, Naoko, Ennishi, Daisuke, Yokoyama, Masahiro, Baba, Satoko, Asaka, Reimi, Mishima, Yuko, Terui, Yasuhito, Hatake, Kiyohiko, Takeuchi, Kengo

Cael y testun llawn Cael y testun llawn Cael y testun llawn

Final results of a phase II study of nivolumab in Japanese patients with relapsed or refractory classical Hodgkin lymphoma gan Maruyama, Dai, Terui, Yasuhito, Yamamoto, Kazuhito, Fukuhara, Noriko, Choi, Ilseung, Kuroda, Junya, Ando, Kiyoshi, Hattori, Akira, Tobinai, Kensei

Cael y testun llawn Cael y testun llawn Cael y testun llawn

Incidence and risk factors for febrile neutropenia in Japanese patients with non-Hodgkin B cell lymphoma receiving R-CHOP: 2-year experience in a single center (STOP FN in NHL 2) gan Yokoyama, Masahiro, Kusano, Yoshiharu, Nishihara, Anna, Inoue, Norihito, Nishimura, Noriko, Mishima, Yuko, Terui, Yasuhito, Nukada, Tomoyuki, Nomura, Takanobu, Hatake, Kiyohiko

Cael y testun llawn Cael y testun llawn Cael y testun llawn

Phase I study of obinutuzumab (GA101) in Japanese patients with relapsed or refractory B‐cell non‐Hodgkin lymphoma gan Ogura, Michinori, Tobinai, Kensei, Hatake, Kiyohiko, Uchida, Toshiki, Suzuki, Tatsuya, Kobayashi, Yukio, Mori, Masakazu, Terui, Yasuhito, Yokoyama, Masahiro, Hotta, Tomomitsu

Cael y testun llawn Cael y testun llawn Cael y testun llawn

A phase 2, open-label, multicenter study of ixazomib plus lenalidomide and dexamethasone in adult Japanese patients with relapsed and/or refractory multiple myeloma gan Iida, Shinsuke, Izumi, Tohru, Komeno, Takuya, Terui, Yasuhito, Chou, Takaaki, Ikeda, Takashi, Berg, Deborah, Fukunaga, Shinichi, Sugiura, Kenkichi, Sasaki, Makoto

Cael y testun llawn Cael y testun llawn Cael y testun llawn

Absolute peripheral monocyte count at diagnosis predicts central nervous system relapse in diffuse large B-cell lymphoma gan Nitta, Hideaki, Terui, Yasuhito, Yokoyama, Masahiro, Mishima, Yuko, Nishimura, Noriko, Ueda, Kyoko, Kusano, Yoshiharu, Tsuyama, Naoko, Takeuchi, Kengo, Kanda, Yoshinobu, Hatake, Kiyohiko

Cael y testun llawn Cael y testun llawn Cael y testun llawn

Incidence and risk factors of febrile neutropenia in patients with non-Hodgkin B-cell lymphoma receiving R-CHOP in a single center in Japan gan Yokoyama, Masahiro, Kusano, Yoshiharu, Takahashi, Anna, Inoue, Norihito, Ueda, Kyoko, Nishimura, Noriko, Mishima, Yuko, Terui, Yasuhito, Nukada, Tomoyuki, Nomura, Takanobu, Hatake, Kiyohiko

Cael y testun llawn Cael y testun llawn Cael y testun llawn

HIV positivity may not have a negative impact on survival in Epstein-Barr virus-positive Hodgkin lymphoma: A Japanese nationwide retrospective survey gan Yotsumoto, Mihoko, Ito, Yoshikazu, Hagiwara, Shotaro, Terui, Yasuhito, Nagai, Hirokazu, Ota, Yasunori, Ajisawa, Atsushi, Uehira, Tomoko, Tanuma, Junko, Ohyashiki, Kazuma, Okada, Seiji

Cael y testun llawn Cael y testun llawn Cael y testun llawn

Infusion Rate Escalation Study of Rituximab in Patients with CD20+ B-Cell Lymphomas: A Single Institution Analysis in Japan gan Yokoyama, Masahiro, Terui, Yasuhito, Takeuchi, Kengo, Nara, Eriko, Nakano, Kenji, Ueda, Kyoko, Nishimura, Noriko, Mishima, Yuko, Sakajiri, Sakura, Tsuyama, Naoko, Ozawa, Keiya, Hatake, Kiyohiko

Cael y testun llawn Cael y testun llawn Cael y testun llawn

CTNI-66. ONE-YEAR FOLLOW-UP DATA OF PHASE I/II STUDY OF TIRABRUTINIB IN PATIENTS WITH RELAPSED OR REFRACTORY PRIMARY CENTRAL NERVOUS SYSTEM LYMPHOMA gan Mishima, Kazuhiko, Narita, Yoshitaka, Nagane, Motoo, Terui, Yasuhito, Arakawa, Yoshiki, Yonezawa, Hajime, Asai, Katsunori, Fukuhara, Noriko, Sugiyama, Kazuhiko, Shinojima, Naoki, Aoi, Arata, Nishikawa, Ryo

Cael y testun llawn Cael y testun llawn

ML-05 One-year follow-up data of phase I/II study of tirabrutinib in patients with relapsed or refractory primary central nervous system lymphoma gan Mishima, Kazuhiko, Narita, Yoshitaka, Nagane, Motoo, Terui, Yasuhito, Arakawa, Yoshiki, Yonezawa, Hajime, Asai, Katsunori, Fukuhara, Noriko, Sugiyama, Kazuhiko, Shinojima, Naoki, Aoi, Arata, Nishikawa, Ryo

Cael y testun llawn Cael y testun llawn

Safety and pharmacokinetics of polatuzumab vedotin in Japanese patients with relapsed/refractory B-cell non-Hodgkin lymphoma: a phase 1 dose-escalation study gan Kinoshita, Tomohiro, Hatake, Kiyohiko, Yamamoto, Kazuhito, Higuchi, Yusuke, Murakami, Satsuki, Terui, Yasuhito, Yokoyama, Masahiro, Maruyama, Dai, Makita, Shinichi, Hida, Yukari, Saito, Tomohisa, Tobinai, Kensei

Cael y testun llawn Cael y testun llawn Cael y testun llawn

Phase I Study of Ofatumumab, a Human Anti-CD20 Antibody, in Japanese Patients with Relapsed or Refractory Chronic Lymphocytic Leukemia and Small Lymphocytic Lymphoma gan Ogura, Michinori, Hatake, Kiyohiko, Tobinai, Kensei, Uchida, Toshiki, Suzuki, Tatsuya, Terui, Yasuhito, Yokoyama, Masahiro, Maruyama, Dai, Mori, Masakazu, Jewell, Roxanne C., Katsura, Koichi, Hotta, Tomomitsu

Cael y testun llawn Cael y testun llawn Cael y testun llawn